Trends in Multidrug‐ResistantMycobacterium tuberculosisin Relation to Sputum Smear Positivity in Hong Kong, 1989–1999
Open Access
- 1 February 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (3) , 324-329
- https://doi.org/10.1086/338067
Abstract
We studied retrospectively the territory-wide occurrence and trends of multidrug-resistant tuberculosis (MDR-TB) in Hong Kong over an 11-year period during which a short-course directly observed therapy (“DOTS-Plus”) strategy has been in operation. The overall MDR rate was 2.1% (primary, 1.4% and acquired, 9.5%) and declined at 0.08% per year: smear-positive primary MDR cases declined at yearly rate of -0.065% (R2 = .23), and smear-negative primary MDR cases increased at 0.035% yearly. With declining rates of smear positivity, sputum culture has become the mainstay of detection of MDR-TB. Although the overall notification rates showed the elderly (age >65 years) age group to be most affected, the occurrence of MDR-TB has been consistently highest in the 35–65 year age group (60.4% of MDR caseload). We demonstrated declining rates of sputum smear positivity of MDR-TB in a DOTS-plus environment and that a centralized laboratory database is essential in gathering epidemiological information for identifying particular risk groups and monitoring trends of MDR-TB in a community.Keywords
This publication has 15 references indexed in Scilit:
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000
- Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus"BMJ, 1998
- Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997New England Journal of Medicine, 1998
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control ProgramsAmerican Review of Respiratory Disease, 1991
- Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis second report: the results up to 24 monthsTubercle, 1982
- Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: The results up to 24 monthsTubercle, 1979
- Drug-resistance in patients with pulmonary tuberculosis presenting at chest clinics in Hong KongTubercle, 1964
- Development of Streptomycin Resistant Strains of Tubercle Bacilli in Pulmonary Tuberculosis: Results of Simultaneous Sensitivity Tests in Liquid and on Solid MediaThorax, 1950
- Streptomycin Resistance in Pulmonary TuberculosisBMJ, 1948